Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Muscle-invasive Bladder Cancer”

477 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 477 results

Not applicableLooking for participantsNCT06991868
What this trial is testing

Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

Who this might be right for
NMIBCMIBCUTUC
Peking University First Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02343614
What this trial is testing

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non Muscle Invasive Bladder Cancer
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 58
Testing effectiveness (Phase 2)Ended earlyNCT03719300
What this trial is testing

Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Anchiano Therapeutics Israel Ltd. 32
Not applicableStudy completedNCT01004211
What this trial is testing

Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging

Who this might be right for
Non Muscle Invasive Bladder Cancer
Paolo Puppo 188
Large-scale testing (Phase 3)Study completedNCT00330707
What this trial is testing

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
National University Hospital, Singapore 140
Not applicableUnknownNCT04664816
What this trial is testing

Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Mansoura University 110
Testing effectiveness (Phase 2)UnknownNCT04738630
What this trial is testing

Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Taizhou Hanzhong biomedical co. LTD 110
Not applicableStudy completedNCT02298998
What this trial is testing

Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study

Who this might be right for
Bladder Cancer
The University of Texas Health Science Center at San Antonio 41
Not applicableLooking for participantsNCT07673016
What this trial is testing

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Who this might be right for
Bladder CancerUrothelial Carcinoma (UC)Hematuria+1 more
Convergent Genomics, Inc. 2,500
Large-scale testing (Phase 3)Active Not RecruitingNCT03091660
What this trial is testing

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Who this might be right for
Stage 0 Bladder Urothelial CarcinomaStage 0is Bladder Urothelial CarcinomaStage I Bladder Urothelial Carcinoma
SWOG Cancer Research Network 1,000
Early research (Phase 1)Looking for participantsNCT06186414
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Jiangsu Simcere Pharmaceutical Co., Ltd. 152
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Testing effectiveness (Phase 2)Looking for participantsNCT05327647
What this trial is testing

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
CHU de Quebec-Universite Laval 160
Early research (Phase 1)WithdrawnNCT00014287
What this trial is testing

Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer

Who this might be right for
Bladder Cancer
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00491114
What this trial is testing

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

Who this might be right for
Bladder Neoplasms
Eli Lilly and Company 8
Large-scale testing (Phase 3)UnknownNCT01082510
What this trial is testing

Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)

Who this might be right for
Bladder Cancer
Urological Oncology Council of Northern Tokyo 288
Not applicableWithdrawnNCT03839472
What this trial is testing

Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)Bladder Tumor (TURBT)
Case Comprehensive Cancer Center
Not applicableUnknownNCT05704231
What this trial is testing

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder CancerSelf EfficacySmoking Behaviors+2 more
Bakirkoy Dr. Sadi Konuk Research and Training Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT05710848
What this trial is testing

STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
SURGE Therapeutics 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06630871
What this trial is testing

A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.

Who this might be right for
NMIBC
Fujian Medical University Union Hospital 40
Next Page